QA: Provectus Biopharmaceuticals INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000315545_2024_Provectus_Biopharmaceuticals_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000315545, Provectus Biopharmaceuticals INC

  xvar xval
0 AssetsCurrent 1,364,797
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 12,020
3 remainder_Assets 72,026
4 LiabilitiesCurrent 9,016,895
5 LiabilitiesNoncurrent 25,299
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,687,936
9 ResearchAndDevelopmentExpense 1,710,579
10 remainder_Expenses 0
11 remainder_Revenues 690,428
12 remainder_NetIncome -199,938
13 remainder_ComprehensiveNetIncome -140,855
  yvar yval
0 Assets 1,448,843
1 Liabilities 9,042,194
2 Expenses 3,398,515
3 Revenues 690,428
4 StockholdersEquity -7,593,351
5 NetIncome -2,908,025
6 ComprehensiveNetIncome -2,978,452
7 BaseVar 7,460,386
8 EconomicCapitalRatiobeforeLimitedLiability -3.72
9 EconomicCapitalRatio 0.465

Edgar->Model Mapping

Feature Distribution

Change over Time